QTc shortening agents

DBCAT003890Pharmacologic class

Drugs demonstrated to have QTc interval shortening properties, which may lead to ventricular tachyarrhythmias. A DrugBank category of 2 drugs. 2 of them are approved.

Drugs: Aripiprazole
Atenolol

What you can answer from here — as of April 11, 2019

2DrugsEach linked to its full drug card

Listed above

38Drug targetsEvery drug–target pair in the class, with bond type

3,344Marketed productsAcross the regions we cover, with dosage forms and routes

7Routes of administrationHow the drugs in this class are given

Which targets do QTc shortening agents share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account